Orgenesis Stock Alpha and Beta Analysis
| ORGS Stock | USD 0.52 0.01 1.96% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Orgenesis. It also helps investors analyze the systematic and unsystematic risks associated with investing in Orgenesis over a specified time horizon. Remember, high Orgenesis' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Orgenesis' market risk premium analysis include:
Beta 4.86 | Alpha 0.88 | Risk 10.79 | Sharpe Ratio 0.13 | Expected Return 1.41 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Orgenesis |
Orgenesis Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Orgenesis market risk premium is the additional return an investor will receive from holding Orgenesis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orgenesis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Orgenesis' performance over market.| α | 0.88 | β | 4.86 |
Orgenesis expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Orgenesis' Buy-and-hold return. Our buy-and-hold chart shows how Orgenesis performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Orgenesis Market Price Analysis
Market price analysis indicators help investors to evaluate how Orgenesis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By understating and applying Orgenesis stock market price indicators, traders can identify Orgenesis position entry and exit signals to maximize returns.
Orgenesis Return and Market Media
The median price of Orgenesis for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 is 0.51 with a coefficient of variation of 39.06. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 0.55, and mean deviation of 0.19. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | EXCLUSIVE Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic | 01/31/2024 |
2 | Purchase by Safier Jacob of 5000 shares of Orgenesis | 02/14/2024 |
3 | Dakota Gold And 2 Other Stocks Under 3 Insiders Are Buying - MSN | 02/15/2024 |
4 | Orgenesis announces 2.3M private placement | 03/04/2024 |
5 | Orgenesis Trading Down 4.2 percent - Defense World | 03/11/2024 |
6 | Acquisition by Neil Reithinger of 16667 shares of Orgenesis at 6.0 subject to Rule 16b-3 | 03/22/2024 |
7 | Acquisition by David Sidransky of tradable shares of Orgenesis at 5.42 subject to Rule 16b-3 | 03/28/2024 |
8 | Acquisition by Victor Miller of 25000 shares of Orgenesis at 0.5 subject to Rule 16b-3 | 04/01/2024 |
9 | Orgenesis Shares Down 33.4 percent - Defense World | 04/02/2024 |
10 | Acquisition by Safier Jacob of 20000 shares of Orgenesis at 0.6527 subject to Rule 16b-3 | 04/05/2024 |
11 | Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Gl... | 04/10/2024 |
12 | Orgenesis secures 2.3 million investment and strategic partnership | 04/15/2024 |
About Orgenesis Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Orgenesis or other stocks. Alpha measures the amount that position in Orgenesis has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.001365 | 0.001213 | Price To Sales Ratio | 27.4 | 28.77 |
Orgenesis Upcoming Company Events
As portrayed in its financial statements, the presentation of Orgenesis' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Orgenesis' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Orgenesis' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Orgenesis. Please utilize our Beneish M Score to check the likelihood of Orgenesis' management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Orgenesis
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Orgenesis Backtesting, Orgenesis Valuation, Orgenesis Correlation, Orgenesis Hype Analysis, Orgenesis Volatility, Orgenesis History and analyze Orgenesis Performance. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Orgenesis Stock analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Orgenesis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.